亚太地区临床试验市场预测至 2028 年 – 区域分析 – 按研究设计（介入性、观察性和扩大访问）、阶段（第一阶段、第二阶段、第三阶段和第四阶段）和适应症（自身免疫/炎症、疼痛管理、肿瘤、中枢神经系统疾病、糖尿病、肥胖、心血管等）
No. of Pages: 145 | Report Code: BMIRE00028988 | Category: Life Sciences
No. of Pages: 145 | Report Code: BMIRE00028988 | Category: Life Sciences
人工智能 (AI) 的采用提供了收集和管理临床试验数据的创新方法，并减少了对手动操作的依赖。因此，人工智能对于参与药物开发过程的生命科学公司来说是游戏规则的改变者。
阿斯利康的肿瘤数据科学团队将这些数据输入到利用人工智能和其他统计工具可以为肿瘤药物开发产生新的假设。为了改变肿瘤学数据馈送的流程，该团队根据“GOFAIR（数字资产的可查找性、可访问性、互操作性和重用性）”原则，采用复杂的数据集来实现数据的可访问性、互操作性和可重用性。这种集成使公司的药物开发团队能够根据数据保护法收集特定临床试验和项目的数据。
阿斯利康与 Tempus 等公司合作，利用真实世界的数据并代表全球患者。这种战略合作伙伴关系预计将提供有关患者结果的重要证据，而不会透露数据集中临床试验参与者的身份。
亚太地区 (APAC) 是全球临床试验增长最快的区域市场，分为中国、日本、印度、韩国、澳大利亚、印度尼西亚、泰国、越南以及亚太其他地区。由于医疗保健行业的不断发展，澳大利亚、印度和韩国等国家预计将出现各种增长机会。此外，这些国家的政府正在加大力度提供临床试验。此外，慢性病发病率的上升和对临床试验的认识不断增强可能会在未来几年为市场参与者提供更大的增长机会。
< span>
亚太地区临床试验市场分为阶段、研究设计、适应症和国家。< /span>
根据阶段，亚太临床试验市场分为 I 期、II 期、III 期和 IV 期。 2022年，III期临床试验市场份额最大。
根据研究设计，亚太临床试验市场分为介入性、观察性和扩展性使用权。 2022年，介入细分市场占据亚太地区最大的临床试验市场份额。
根据适应症，亚太临床试验市场分为自身免疫/炎症、疼痛管理、肿瘤学、中枢神经系统疾病、糖尿病、肥胖、心血管等。 2022年，肿瘤学领域占据亚太地区最大的临床试验市场份额。
按国家划分，亚太地区临床试验市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。 2022 年，中国在亚太临床试验市场占据主导地位。
Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、Laboratory Corp of America Holdings、Parexel International Corp、 SGS SA、SIRO Clinpharm Pvt Ltd、Syneos Health Inc、Thermo Fisher Scientific Inc 和 WuXi AppTec Co Ltd. 是亚太临床试验市场上的一些领先公司。
Strategic insights for Asia Pacific Clinical Trials involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 8,670.68 Million |
| Market Size by 2028 | US$ 13,114.04 Million |
| Global CAGR (2022 - 2028) | 7.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 研究设计
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Clinical Trials refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Clinical Trials Market is valued at US$ 8,670.68 Million in 2022, it is projected to reach US$ 13,114.04 Million by 2028.
As per our report Asia Pacific Clinical Trials Market, the market size is valued at US$ 8,670.68 Million in 2022, projecting it to reach US$ 13,114.04 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The Asia Pacific Clinical Trials Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Clinical Trials Market report:
The Asia Pacific Clinical Trials Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Clinical Trials Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Clinical Trials Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Clinical Trials Market
